SB-269970
SB-269970 Uses, Dosage, Side Effects, Food Interaction and all others data.
SB-269970 is an experimental drug developed by GlaxoSmithKline. In the studies performed with this agent, it has been suggested that SB-269970 acts either as a selective antagonist or inverse agonist of the serotonin receptor 7 (5-HT7).
| Trade Name | SB-269970 |
| Generic | SB-269970 |
| Type | |
| Formula | C18H28N2O3S |
| Weight | Average: 352.49 Monoisotopic: 352.182063944 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here SB-269970
